Irish Cancer Society invests €3.1m in research
Cancer research has received a €3.1m boost from the Irish Cancer Society, which has awarded the funds to eight Irish Cancer Society research scholars.
Four research fellows and four prostate cancer researchers will use the funds for new research projects in leukaemia, cancer involving the lungs, breasts, ovaries and prostate, as well as colorectal, oesophageal and metastatic cancers.
More specifically, one Irish research project to benefit from the funds aims to improve the effectiveness of radiation therapy for prostate cancer patients.
Cancer remains a major cause of death and disease in Ireland, according to the Irish Cancer Society. More than 30,000 people are diagnosed with the disease every year.
Source: Silicon Republic
Similar entries
- Research could lead to better diagnosis of prostate cancer
- Men unaware of cancer risks
- Pros and cons of cancer screening
- Scientists develop prostate vaccine
- Older men get less effective prostate cancer care : new US study
- Raising awareness on oesophageal cancer
- Lifestyle and ageing behind projected 72% rise in cancers
- Blood clot risk for men with prostate cancer
- Special Focus Issue: Prostate cancer in the elderly population
- 'Marked improvement' in cancer treatment





